RxSight (RXST) Other Non-Current Liabilities (2020 - 2025)

RxSight (RXST) has 5 years of Other Non-Current Liabilities data on file, last reported at $3.2 million in Q4 2025.

• For the quarter ending Q4 2025, Other Non-Current Liabilities rose 88.24% year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (up 88.24% YoY), and the FY2025 full-year result was $3.2 million, up 88.24% from the prior year.
• Other Non-Current Liabilities for Q4 2025 stood at $3.2 million, up from $1.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $3.2 million in Q4 2025 and bottomed at $74000.0 in Q4 2023.
• The 4-year median for Other Non-Current Liabilities is $888000.0 (2023), against an average of $1.3 million.
• The widest annual swing landed in 2024, when Other Non-Current Liabilities soared 2197.3%; it then jumped 88.24% in 2025.
• A 4-year view of Other Non-Current Liabilities shows it stood at $2.6 million in 2021, then plunged by 97.17% to $74000.0 in 2023, then jumped by 2197.3% to $1.7 million in 2024, then surged by 88.24% to $3.2 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $3.2 million (Q4 2025), $1.7 million (Q4 2024), and $74000.0 (Q4 2023), per Business Quant data.

Peer Comparison